Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.

Item
http://www.wikidata.org/entity/Q43910342
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatmPrevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.Antigen-driven bystander suppression after oral administration of antigens.Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggeringSmall molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulinExperimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?Immunologic mechanisms and therapy in multiple sclerosis.IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.Oral desensitisation in rheumatoid arthritis.Oral tolerance: elucidation of mechanisms and application to treatment of autoimmune diseases.Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides.Oral administration of collagen conjugated with cholera toxin induces tolerance to type II collagen and suppresses chondritis in an animal model of autoimmune ear disease.Neurotrophic ACTH4-9 analogue therapy normalizes electroencephalographic alterations in chronic experimental allergic encephalomyelitis.Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial.
P2860

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.

Item
http://www.wikidata.org/entity/Q43910342
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Suppression of experimental au ...... rat and strain 13 guinea pig.
@en
Suppression of experimental au ...... rat and strain 13 guinea pig.
@nl
type
label
Suppression of experimental au ...... rat and strain 13 guinea pig.
@en
Suppression of experimental au ...... rat and strain 13 guinea pig.
@nl
prefLabel
Suppression of experimental au ...... rat and strain 13 guinea pig.
@en
Suppression of experimental au ...... rat and strain 13 guinea pig.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Suppression of experimental au ...... rat and strain 13 guinea pig.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698